Keyword(s): Small molecules
-
Jose Halperin, MD
Targeting protein translation for anticancer therapies; CD59 and diabetes
Employ the preclinical resources of the Laboratory for Translational Research to develop new therapies and diagnostics in oncology and diabetes

-
David Sinclair, PhD
Sirtuins in aging and disease: calorie restriction; mitochondria; cancer; diabetes
Study sirtuin pathways, their role in multiple diseases and their lifespan extension capabilities.

-
Priscilla Yang, PhD
Host response to viral infection and drug discovery: dengue virus, hepatitis B and C viruses
Investigate molecular mechanisms of dengue and hepatitis virus infection and replication; perform HTS for viral antagonists to identify host factors and pathways required for dengue virus infection ...

Research Categories
Sub-categories
-
Drug Development: Non-Biologic Therapeutics and Small Molecules
- Adamantane»
- Anti-bacterial therapy»
- Anti-convulsant therapy»
- Anti-viral therapeutics»
- Anticancer therapy»
- Anticoagulant»
- Anticonvulsant therapy»
- Antifungal»
- Antimicrobial»
- Antioxidant»
- Antiviral small molecules»
- Antizyme»
- Anxiolytic»
- Benzodiazepine»
- Biologically-active small molecule»
- Cancer targets»
- Combination therapy»
- D-amino acids»
- DNA damaging agents»
- Double mimetic»
- EdU»
- HAART»
- Iressa»
- Medicinal chemistry»
- Muscle relaxant»
- Natural product»
- Natural products»
- Opioid»
- Peptide mimetic»
- Pharmacological agents»
- Prodrug»
- Recombinant toxins»
- Resveratol»
- Sedative»
- Small molecule chemistry»
- Small molecule inhibitors»
- Small molecule screens»
- Small molecule therapy»
- Small molecules»
- Soil microbe»
- Tarceva»